GenScript Reports 27.3% First-Half 2026 Revenue Growth as AI Drug Discovery Business Doubles

Contributed by: PR Newswire

Images

PR Newswire associated0

PR Newswire associated1

Tags

GenScript-finc-report

More Like This

PR Newswire associated0

GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth

PR Newswire associated0

'Scripting Possibilities' in Biotechnology: Global Innovators Converge in San Francisco for GenScript's 5th Annual Biotech Forum During JPM Week

PR Newswire associated0

GenScript Sets New Benchmark for Responsible Biotech Leadership with 2025 ESG Report

PR Newswire associated0

Viva Biotech Announces 2025 Annual Results: AI-Driven Drug Discovery Reinforces Industry Leadership, CDMO Commercial Products Enter Rapid Scale-Up

(Graphic: Business Wire)

BeiGene Enters Next Phase of Global Growth with Announcement of Second Quarter 2024 Financial Results and Corporate Updates

BeiGene Announces First Quarter 2025 Financial Results and Business Updates

PR Newswire associated0

GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub

BeiGene Reports First Quarter 2024 Financial Results and Business Updates